NCT05399628

Brief Summary

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 1, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

June 6, 2022

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2022

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

5 days

First QC Date

May 26, 2022

Last Update Submit

July 21, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants who will achieve the positioning of the device at the correct depth in the trachea

    Number of participants who will achieve the positioning of the device at the correct depth in the trachea (as assessed by the external observer using a laryngoscope).

    5 minutes

Secondary Outcomes (3)

  • Time for positioning the device in the trachea

    5 minutes

  • Number of attempts for positioning the device in the trachea

    5 minutes

  • Participant opinion on using the device

    10 minutes

Study Arms (2)

Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

EXPERIMENTAL

Participants will be assigned to perform the procedure with a LISA catheter with a marked tip

Device: Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

ACTIVE COMPARATOR

Participants will be assigned to perform the procedure with a LISA catheter with an unmarked tip

Device: Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

Interventions

Participants will be assigned to perform the procedure with LISA catheter with a marked tip

Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

Participants will be assigned to perform the procedure with LISA catheter with an unmarked tip

Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Level III NICU consultants and residents will be eligible to participate in the study

You may not qualify if:

  • Refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Daniele Trevisanuto

Padua, 35128, Italy

Location

Related Publications (1)

  • Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.

    PMID: 30974433BACKGROUND

MeSH Terms

Conditions

Respiratory Distress Syndrome, Newborn

Condition Hierarchy (Ancestors)

Respiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the characteristics of the intervention, both participants and outcome assessors cannot be masked. The statistician will be blind to the intervention arms.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants in AB arm will be assigned to perform the procedure with LISA catheter with marked tip, followed by the procedure with LISA catheter with unmarked tip. Participants in BA arm will be assigned to the reverse sequence. A washout period of 6 hours (one procedure in the morning and one in the afternoon) will be included to reduce any carryover effect
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 26, 2022

First Posted

June 1, 2022

Study Start

June 6, 2022

Primary Completion

June 11, 2022

Study Completion

June 11, 2022

Last Updated

July 26, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

The data will be available upon motivated request to the corresponding author

Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations